// App-Quantinova.ai

: Validity of ROX Index for Nasal High Flow Therapy in Critical Care

Researchers

Presenter

  • Raquel Mehmel D´Espiney Madeira Barbara

Principal Investigators

  • Joe Vincent

  • James Kelly

  • Vladimir Macavei

  • Juan Martin-Lazaro

Medical Centers

  • Neonatal Unit, Croydon University Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Roxithromycin

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved